Short-term estrogen augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilation in postmenopausal women

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 4, 1997, Pages 481-488

  Tagawa, Hirofumi ^a   Shimokawa, Hiroaki ^a   Tagawa, Tatsuya ^a   Kuroiwa Matsumoto, Mari ^a   Hirooka, Yoshitaka ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Endothelium; Endothelium derived relaxing factors; Estrogen; Nitric oxide

Indexed keywords

ACETYLCHOLINE; CONJUGATED ESTROGEN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTACYCLIN; SUBSTANCE P;

ADULT; AGED; ARM BLOOD FLOW; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; PLETHYSMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

AGED; ARM; ENDOTHELIUM, VASCULAR; ESTROGENS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MIDDLE AGED; NITRIC OXIDE; POSTMENOPAUSE; VASODILATION;

EID: 0030707830     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199710000-00012     Document Type: Article

References (45)

1. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham Study. Ann Intern Med 1976;85:447-52.
2. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program follow-up study. Circulation 1987;75:1102-9.
3. Sullivan JM, Zwaag RV, Lemp GF, et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988:108:358-63.
4. Barrett-Connor E, Bush TL. Estrogens and coronary heart disease in women. JAMA 1991;265:1861-7.
5. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991;325:756-62.
6. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991:325:1196-204.
7. Wagner JD, Clarkson TB, St. Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest 1991;88:1995-2002.
8. Negre-Salvayre A, Pieraggi MT, Mabile L, Salvayre R. Protective effect of 17-β-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis 1993:89:209-17.
9. Fischer GM, Swain ML. Effect of sex hormones on blood pressure and vascular connective tissue in castrated and noncastrated male rats. Am J Pliysiol 1977;232:H617-21.
10. Reis SE, Gloth ST, Blumenthal RS, et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994;89:52-60.
11. Gilligan DM, Quyyumi AA, Cannon RO. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994:89:2545-51.
12. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994:90:786-91.
13. Williams JK, Adams MR, Klopfenstein S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;81:1680-7.
14. Williams JK, Adams MR, Herrington DM, Clarkson TB. Shortterm administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992;20:452-7.
15. Chang WC, Nakao J, Orimo H, Murota S. Stimulation of prostacyclin biosynthetic activity by estradiol in rat aortic smooth muscle cells in culture. Biochim Biophys Acta 1980;619:107-18.
16. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17βoestradiol in vitro. Br J Phannacol 1991;104:1033-7.
17. Lüscher TF, Vanhoutte PM. The endotheliitm: modulator of cardiovascular function. Boca Raton: CRC Press, 1990:1-228.
18. Nagao T, Vanhoutte PM. Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations. Am J Resp Cell Mol Biol 1993;8:l-6.
19. Shimokawa H, Vanhoutte PM. Endothelium and vascular injury in hypertension and atherosclerosis. In: Zanchetti A, Mancia G, eds. Handbook of hypertension. Amsterdam: Elsevier Science, 1997: 1007-68.
20. Shiramoto M, Imaizumi T, Hirooka Y, et al. Role of nitric oxide toward vasodilator effects of substance P and adenosine 5′-triphosphate in human forearm vessels. Clin Sci.1997;92:123-31.
21. Imaizumi T, Hirooka Y, Masaki H, et al. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension 1992;20:511-7.
22. Laiberman EH, Gerhard M, Yeung AC, et al. Estrogen improves coronary vasomotor responses to acetylcholine in post menopausal women [Abstract]. Circulation 1993;88:I-79.
23. Haning R, Orczyk GP, Caldwell BV, Behrman HR. Plasma estradiol, estrone, estriol, and urinary estriol glucuronide. In: Jaffe BM, Behrman HR, eds. Methods of hormone radioimmnnoassay. New York: Academic Press, 1979:675-700.
24. Losordo DW, Kearney M, Kirn EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994; 89:1501-10.
25. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptors. Circulation 1994;89:1943-50.
26. Hayashi T, Yamada K, Esaki T, et al. Estrogen increases endotheHal nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 1995:214:847-55.
27. Hishikawa K, Nakai T, MarumoT, Suzuki H, Kato H, SarutaT. Upregulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 1995;360:291-3.
28. Hirooka Y, Imaizumi T, Harada S, et al. Endothelium-dependent forearm vasodilation to acetylcholine but not to substance P is impaired in patients with heart failure. J Cardiovasc Pharmacol 1992; 20:5221-5.
29. Yamamoto H, Yoshimura H, Noma M, et al. Preservation of endothelium-dependent vasodilation in the spastic segment of the human epicardial coronary artery by substance P. Am Heart J 1992;123:298-303.
30. Egashira K, Inou T, Yamada A, Hirooka Y, Takeshita A. Preserved endothelium-dependent vasodilation at the spastic site in patients with variant angina. J din Invest 1992:89:1047-52.
31. Okumura K, Yasue H, Ishizaka H, Ogawa H, Fujii H, Yoshimura M. Endothelium-dependent dilator response to substance P in patients with coronary spastic angina. J Am Coll Cardiol 1991;20: 838-44.
32. Linder L, Kiowski W, Bühler FR, Lüscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990:81:1762-7.
33. Beny JL, Brunei PC, Huggel H. Effect of mechanical stimulation, substance P and vasoactive intestinal polypeptide on the electrical and mechanical activities of circular smooth muscles from pig coronary arteries contracted with acetylcholine: role of endothelium. Pharmacology 1986:33:61-8.
34. Bray K, Quast U. Differences in the K-channels opened by cromakalim, acetylcholine and substance P in rat aorta and porcine coronary artery. BrJ Pharmacol 1991;102:585-94.
35. Fiscus RR, Gross DR, Hao H, et al. N-Nttro-L-arginine blocks the second phase but not the first phase of the endothelium-dependent relaxations induced by substance P in isolated rings of pig carotid artery. J Cardiovasc Pharmacol 1992;20:S105-8.
36. Kuroiwa M, Aoki H, Kobayashi S, Nishimura J, Kanaide H. Mechanism of endothelium-dependent relaxation induced by substance P in the coronary artery of the pig. Br J Pharmacol 1995;116: 2040-7.
37. Wallerstedt SM, Bodelsson M. Endothelium-dependent relaxation by substance P in human isolated oriental arteries and veins: relative contribution of prostanoids, nitric oxide and hyperpolarization. Br J Phamacol 1997;120:25-30.
38. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. JAm Coll Cordial 1994;23:1610-6.
39. Gmonomethyl-L-arginine on kinin-induced vasodilation in the human forearm. Br J Clin Phannacol 1994;38:307-10.
40. Newby DE, Hand MF, Ferro CJ, Love MP, Boon NA, Webb DJ. Forearm vasodilatation to substance P is more dependent on nitric oxide than vasodilatation to acetylcholine. din Sci.1997;92:133-8.
41. Shimokawa H, Yasutake H, Fujii K, et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Phannacol 1996;28:703-11.
42. Abraham GE, Odell WD, Swerdloff RS, Hopper K. Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17β during the menstrual cycle. J Clin Endocrinol 1972;34:312-8.
43. Gisclard V, Flavahan NA, Vanhoutte PM. Alpha adrenergic responses of blood vessels of rabbits after ovariectomy and administration of 17β-estradiol. J Phannacol Exp Ther 1987; 240: 466-70.
44. Harder DR, Coulson PB. Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle. J Cell Physlol 1979; 100:375-82.
45. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO III. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am J Cardiol 1995;75:264-8.